InvestorsHub Logo
Followers 0
Posts 58
Boards Moderated 0
Alias Born 06/29/2022

Re: dstock07734 post# 545048

Wednesday, 12/07/2022 3:25:34 AM

Wednesday, December 07, 2022 3:25:34 AM

Post# of 700218
It's not that simple to compare the two trials, as I said in that post I linked to you, the DCVax+poly-iclc trial includes nGBM and rGBM, DCVax+Keytruda only rGBM which has worse outlook than nGBM.

We couldn't compare them unless we knew the median time to recurrence on DC+Poly and would have to exclude the possible WHO grade 3 glioma patients if there were any.

Someone with more knowledge can confirm if this is correct or if there's even more to it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News